1.96

2.62% 0.05

After Hours: 1.95 -0.01 -0.51%

Outlook Therapeutics Inc (OTLK)

Overview News Price History Financials Discussions Forecast Stock Split

Outlook Therapeutics Inc stock is traded at $1.96, with a volume of 3.30M. It is up +2.62% in the last 24 hours and up +49.62% over the past month. Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Previous Close:

$1.91

Open:

$1.93

24h Volume:

3.30M

Relative Volume:

0.72

Market Cap:

$84.84M

Revenue:

Net Income/Loss:

$-51.50M

P/E Ratio:

-0.49

EPS:

-4

Net Cash Flow:

$-47.10M

1W Performance:

+53.12%

1M Performance:

+49.62%

6M Performance:

+11.36%

1Y Performance:

-62.52%

1-Day Range:

$1.84

$1.99

1-Week Range:

$1.36

$2.01

52-Week Range:

$0.79

$5.44

Outlook Therapeutics Inc Stock (OTLK) Company Profile

Name

Outlook Therapeutics Inc

Sector

Healthcare (1130)

Industry

Biotechnology (634)

Phone

(609) 619-3990

Address

111 S. WOOD AVENUE, ISELIN, NJ

Employee

Twitter

Next Earnings Date

2024-08-14

Latest SEC Filings

OTLK's Discussions on Twitter

Compare OTLK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OTLK Outlook Therapeutics Inc	1.96	84.84M	0	-51.50M	-47.10M	-4.00
ARGX Argen X Se Adr	914.59	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	203.56	43.00B	447.02M	-1.18B	-906.14M	-6.1812
VRTX Vertex Pharmaceuticals Inc	421.03	110.50B	11.74B	3.68B	3.34B	14.19
ONC Beone Medicines Ltd Adr	353.79	40.27B	4.98B	69.59M	525.67M	0.5197
REGN Regeneron Pharmaceuticals Inc	702.75	76.23B	14.25B	4.58B	3.88B	41.77

Outlook Therapeutics Inc Stock (OTLK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-29-25	Downgrade	H.C. Wainwright	Buy → Neutral
Aug-28-25	Downgrade	Guggenheim	Buy → Neutral
Dec-02-24	Downgrade	Chardan Capital Markets	Buy → Neutral
Mar-27-24	Upgrade	BTIG Research	Neutral → Buy
Feb-15-24	Upgrade	Chardan Capital Markets	Neutral → Buy
Jan-25-24	Upgrade	Guggenheim	Neutral → Buy
Dec-27-23	Upgrade	CapitalOne	Equal Weight → Overweight
Aug-31-23	Downgrade	Chardan Capital Markets	Buy → Neutral
Aug-31-23	Downgrade	H.C. Wainwright	Buy → Neutral
Aug-30-23	Downgrade	BTIG Research	Buy → Neutral
Aug-30-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Aug-30-23	Downgrade	CapitalOne	Overweight → Equal Weight
Aug-30-23	Downgrade	Guggenheim	Buy → Neutral
Jul-13-23	Initiated	CapitalOne	Overweight
Apr-03-23	Initiated	Guggenheim	Buy
Feb-06-23	Initiated	Cantor Fitzgerald	Overweight
Oct-31-22	Initiated	BTIG Research	Buy
Sep-13-22	Initiated	Chardan Capital Markets	Buy
Sep-11-19	Initiated	Ladenburg Thalmann	Buy
May-16-19	Initiated	Oppenheimer	Outperform
Apr-22-19	Initiated	Ascendiant Capital Markets	Buy

View All

Outlook Therapeutics Inc Stock (OTLK) Latest News

02:34 AM

Why Outlook Therapeutics Inc. stock is a must watch in 2025Earnings Summary Report & Safe Capital Growth Stock Tips - newser.com

02:34 AM

07:49 AM

What analyst consensus implies for Outlook Therapeutics Inc. (41O) stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com

07:49 AM

07:22 AM

Will Outlook Therapeutics Inc. (41ON) stock enhance shareholder valueJobs Report & Verified Momentum Stock Ideas - newser.com

07:22 AM

06:38 AM

How Outlook Therapeutics Inc. stock reacts to Fed rate cutsWeekly Market Report & Technical Pattern Based Signals - newser.com

06:38 AM

06:16 AM

Will Outlook Therapeutics Inc. (41O) stock beat value stocksMarket Movers & Accurate Buy Signal Notifications - newser.com

06:16 AM

06:04 AM

Outlook Therapeutics Shares Surge on Key FDA Regulatory Milestone - Ad-hoc-news.de

06:04 AM

05:01 AM

Is Outlook Therapeutics Inc. stock a smart buy before Fed meetingMarket Risk Analysis & Fast Moving Trade Plans - newser.com

05:01 AM

04:11 AM

How Outlook Therapeutics Inc. (41O) stock trades under stagflationWeekly Trade Review & Trade Opportunity Analysis Reports - newser.com

04:11 AM

02:30 AM

Is Outlook Therapeutics Inc. (41ON) stock expanding market penetrationGold Moves & Real-Time Price Movement Reports - newser.com

02:30 AM

01:17 AM

Is Outlook Therapeutics Inc. (41ON) stock worth buying before Fed actionJuly 2025 Levels & Accurate Intraday Trading Signals - newser.com

01:17 AM

Nov 18, 2025

Is Outlook Therapeutics Inc. stock a dividend growth opportunity2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com

Nov 18, 2025

Is Outlook Therapeutics Inc. (41ON) stock cheap vs fundamentals2025 Market Overview & Weekly Market Pulse Updates - newser.com

Nov 18, 2025

Outlook Therapeutics Inc. stock momentum explainedEarnings Recap Report & Smart Money Movement Tracker - newser.com

Nov 18, 2025

Nov 17, 2025